Inventor · disambiguated record
Carlos Forray
Also filed as: FORRAY CARLOS · FORRAY CARLOS C
18 granted patents·5 pending applications·313 citations·filing 1992–2002
95Inventor score
Top patents by PatentIndex Score
23 records- 0190US5403847AUse of α1C specific compounds to treat benign prostatic hyperlasiaSYNAPTIC PHARMA CORP·Filed 1992·Granted Apr 4, 1995·70 cites·52 claims
- 0288US5861309ADNA endoding human alpha 1 adrenergic receptorsSYNAPTIC PHARMA CORP·Filed 1993·Granted Jan 19, 1999·40 cites·15 claims
- 0383US5610174AUse of α1A -selective adrenoceptor agonists for the treatment of urinary incontinenceSYNAPTIC PHARMA CORP·Filed 1995·Granted Mar 11, 1997·69 cites·3 claims
- 0481US5556753ADNA encoding human α1 adrenegric receptors and uses thereofSYNAPTIC PHARMA CORP·Filed 1994·Granted Sep 17, 1996·24 cites·10 claims
- 0573US6448011B1DNA encoding human alpha 1 adrenergic receptors and uses thereofSYNAPTIC PHARMA CORP·Filed 2000·Granted Sep 10, 2002·3 cites·23 claims
- 0671US5578611AUse of α-1C specific compounds to treat benign prostatic hyperplasiaSYNAPTIC PHARMA CORP·Filed 1994·Granted Nov 26, 1996·21 cites·36 claims
- 0769US5972624AMethod of identifying ligands which bind recombinant galanin receptor (GALR2)SYNAPTIC PHARMA CORP·Filed 1996·Granted Oct 26, 1999·32 cites·6 claims
- 0868US5714381ADNA encoding human alpha 1 adrenergic receptors and uses thereofSYNAPTIC PHARMA CORP·Filed 1995·Granted Feb 3, 1998·13 cites·14 claims
- 0961US7132248B2Uses of galanin GALR2 receptorsLUNDBECK & CO AS H·Filed 2002·Granted Nov 7, 2006·0 cites·32 claims
- 1060US5780485AUse of α1c specific compounds to treat benign prostatic hyperplasiaSYNAPTIC PHARMA CORP·Filed 1995·Granted Jul 14, 1998·13 cites·56 claims
- 1159US6015819AUse of alpha-1C specific compounds to treat benign prostatic hyperplasiaSYNAPTIC PHARMA CORP·Filed 1993·Granted Jan 18, 2000·10 cites·58 claims
- 1256US2003113771A1DNA encoding human alpha 1 adrenergic receptors and uses thereofSYNAPTIC PHARMA CORP·Filed 2002·Application pending·0 cites
- 1356US2003113772A1DNA encoding human alpha 1 adrenergic receptors and uses thereofSYNAPTIC PHARMA CORP·Filed 2002·Application pending·0 cites
- 1455US7060449B2Method of preparing GALR2 receptors compositionLUNDBECK & CO AS H·Filed 2002·Granted Jun 13, 2006·0 cites·10 claims
- 1554US5990128Aα1C specific compounds to treat benign prostatic hyperplasiaSYNAPTIC PHARMA CORP·Filed 1995·Granted Nov 23, 1999·9 cites·20 claims
- 1651US2003022900A1Compositions comprising alpha-1C specific compoundsSYNAPTIC PHARMA CORP·Filed 2002·Application pending·0 cites
- 1751US2003077701A1DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereofFiled 2001·Application pending·0 cites
- 1848US2003176314A1Compounds for the treatment of painFiled 2002·Application pending·0 cites
- 1943US6156518AMethods of using DNA encoding human alpha 1 adrenergic receptorsSYNAPTIC PHARMA CORP·Filed 1999·Granted Dec 5, 2000·2 cites·30 claims
- 2042US6586191B2Method of identifying compounds that bind galanin receptor (GALR2)SYNAPTIC PHARMA CORP·Filed 1997·Granted Jul 1, 2003·4 cites·19 claims
- 2137US6790656B1DNA encoding galanin GALR2 receptorsSYNAPTIC PHARMA CORP·Filed 1997·Granted Sep 14, 2004·1 cites·40 claims
- 2236US6602888B2Use of α1C specific compounds to treat benign prostatic hyperplasiaSYNAPTIC PHARMA CORP·Filed 1999·Granted Aug 5, 2003·1 cites·31 claims
- 2328US6083705ADNA encoding human α 1 adrenergic receptors and uses thereofSYNAPTIC PHARMACEUTICALS CORP·Filed 1998·Granted Jul 4, 2000·1 cites·31 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →